A Phase 2, Open-label Pilot Study of TRV130 for the Treatment of Moderate to Severe Acute Pain Associated With Long Bone Fracture
Phase of Trial: Phase II
Latest Information Update: 07 Jul 2017
At a glance
- Drugs Oliceridine (Primary)
- Indications Pain
- Focus Therapeutic Use
- Sponsors Trevena
- 07 Jul 2017 Status changed from recruiting to discontinued.
- 17 Nov 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 14 Aug 2015 New trial record